BioSante Pharmaceuticals, Inc. (BPAX)

[snupoled]

Win,
1:6 rs if it slips below a buck....Management has done two
rs already and perception of third one is not good...not saying
3 could be a charm but for most under water already...how high
would stock have to go to recoup principal?
they must be having trouble getting their quorum for merger or we
would have gotten an update I hope you are correct that they are
working on better deal for current shareholders.
If I was sitting on a positive safety study for libigel why would
I value cvrs for 40-million? shareholders taken again?
I believe more strongly than in the morning today,,,that shorts
were starting to settle yesterday...and I would not expect news
this week.....this is going to go one way or the other by atleast
a 50cent-buck swing in short order.worst case scenerio 1:6 rs because news of rs could put us under a buck very quickly if management continues to be less than transparent on company specifics and the wise new investors would wait until after safety study and rs to take positions in new bpax. people often wait for after rs to take positions I have seen this many timesbefore